Sarah Pringle
Telehealth tackles the coronavirus and CapVest-backed Curium calls off its potential $3 billion sale.
Barclays and Moelis have been engaged for sell-side financial advice, however the timeline of the process is unclear amid market uncertainty.
As the JPM and Rothschild process for the French nuclear medicine company is put on hold, attention shifts to Webster Equity-backed PharmaLogic, sources told PE Hub.
TSG Consumer makes a big splash in vet care amid other activity in the lower middle market, with L1 Health's Destination Pet buying VitalPet out of bankruptcy following Cortec's recent acquisition of Lap of Love.
More fallout from the coronavirus--healthcare conferences are cancelled but insiders say don't panic
The transaction comes a day after Blackstone's growth-equity team clinched an approximately $730m deal for HealthEdge, representing the strategy's first healthcare-focused investment to date.
KKR is providing new capital from its $1.45bn Healthcare Strategic Growth Fund to fund the merger, as well as to support the continued growth of the combined company.
Coronavirus is the talk of the town and celebrating women in healthcare private equity.
San Francisco's GI Partners scooped up Logibec in January 2015 from OMERS Private Equity.
The Cantor Fitzgerald-run process could result in a sale to one of a small handful of logical strategic buyers, sources said.